{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:13:04Z","timestamp":1785683584075,"version":"3.56.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.mcna.2021.04.010","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T12:21:15Z","timestamp":1622204475000},"page":"737-755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma"],"prefix":"10.1016","volume":"105","author":[{"given":"John A.","family":"Zic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mcna.2021.04.010_bib1","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3390\/cancers12102921","article-title":"Epidemiology of cutaneous T-Cell lymphomas: a systematic review and meta-analysis of 16,953 patients","volume":"12","author":"Dobos","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.010_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ad.2020.08.003","article-title":"Cutaneous Lymphomas - Part I: mycosis fungoides, sezary syndrome, and CD30(+) cutaneous lymphoproliferative disorders","volume":"112","author":"Pujol","year":"2021","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.17258","article-title":"The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients","volume":"181","author":"Scarisbrick","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.010_bib4","doi-asserted-by":"crossref","first-page":"adv00013","DOI":"10.2340\/00015555-3367","article-title":"Early-stage mycosis fungoides: epidemiology and prognosis","volume":"100","author":"Maguire","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"11","key":"10.1016\/j.mcna.2021.04.010_bib5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","article-title":"Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis","volume":"132","author":"Kim","year":"1996","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2021.04.010_bib6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2013.12.029","article-title":"Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement","volume":"70","author":"Hodak","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ad.2019.04.004","article-title":"Mycosis fungoides in children and adolescents: a series of 23 cases","volume":"111","author":"Valencia Ocampo","year":"2020","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaad.2019.08.073","article-title":"Outcomes and prognostic factors in African American and black patients with mycosis fungoides\/Sezary syndrome: retrospective analysis of 157 patients from a referral cancer center","volume":"83","author":"Geller","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"23","key":"10.1016\/j.mcna.2021.04.010_bib9","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1002\/cncr.27627","article-title":"Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas","volume":"118","author":"Quaglino","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.010_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.det.2019.08.013","article-title":"Phototherapy for cutaneous T-Cell lymphoma","volume":"38","author":"Marka","year":"2020","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.010_bib11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjd.19252","article-title":"Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Study (PROCLIPI study)","volume":"184","author":"Quaglino","year":"2021","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.010_bib12","doi-asserted-by":"crossref","DOI":"10.5070\/D3225030939","article-title":"Tumor stage mycosis fungoides: a single-center study on clinicopathologic features, treatments, and patient outcome","volume":"22","author":"Patrawala","year":"2016","journal-title":"Dermatol Online J"},{"issue":"10","key":"10.1016\/j.mcna.2021.04.010_bib13","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/annonc\/mdx352","article-title":"Global patterns of care in advanced stage mycosis fungoides\/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium","volume":"28","author":"Quaglino","year":"2017","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.mcna.2021.04.010_bib14","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.3390\/cancers12102856","article-title":"Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas","volume":"12","author":"Dumont","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5 Suppl 1","key":"10.1016\/j.mcna.2021.04.010_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1590\/abd1806-4841.20175634","article-title":"Folliculotropic mycosis fungoides: challenging clinical, histopathological and immunohistochemical diagnosis","volume":"92","author":"Malveira","year":"2017","journal-title":"An Bras Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/DAD.0000000000001698","article-title":"Acneiform presentations of folliculotropic mycosis fungoides","volume":"43","author":"Shamim","year":"2021","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.010_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/cup.13615","article-title":"Plaque stage folliculotropic mycosis fungoides: histopathologic features and prognostic factors in a series of 40 patients","volume":"47","author":"van Santen","year":"2020","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.010_bib18","doi-asserted-by":"crossref","first-page":"e13585","DOI":"10.1111\/dth.13585","article-title":"Folliculotropic mycosis fungoides: Clinical characteristics, treatments, and long-term outcomes of 53 patients in a tertiary hospital","volume":"33","author":"Kalay Yildizhan","year":"2020","journal-title":"Dermatol Ther"},{"issue":"17","key":"10.1016\/j.mcna.2021.04.010_bib19","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1503\/cmaj.141318","article-title":"Woringer-Kolopp disease mimicking psoriasis","volume":"187","author":"Wang","year":"2015","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.mcna.2021.04.010_bib20","first-page":"307","article-title":"Woringer-Kolopp disease mimicking foot dermatitis","volume":"90","author":"Yao","year":"2012","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.010_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jdcr.2018.10.023","article-title":"Pagetoid reticulosis (Woringer-Kolopp disease) in a 2-year-old girl-Case report and review of the literature","volume":"5","author":"Corbeddu","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib22","doi-asserted-by":"crossref","first-page":"e14822","DOI":"10.1111\/dth.14822","article-title":"Granulomatous slack skin variant of mycosis fungoides: clinical and dermoscopic follow-up of a very rare entity","volume":"34","author":"Swoboda","year":"2021","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.010_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1684\/ejd.2008.0562","article-title":"Granulomatous slack skin clinically and histologically masquerading as borderline leprosy in its early stages","volume":"19","author":"Pratchyapruit","year":"2009","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2133.1994.tb08505.x","article-title":"Granulomatous slack skin: report of a case associated with Hodgkin's disease and a review of the literature","volume":"131","author":"Noto","year":"1994","journal-title":"Br J Dermatol"},{"issue":"6\u20137","key":"10.1016\/j.mcna.2021.04.010_bib25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.annder.2017.03.010","article-title":"[Granulomatous slack skin associated with metastatic testicular seminoma]","volume":"144","author":"Carton de Tournai","year":"2017","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.010_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/ijd.13155","article-title":"Granulomatous slack skin: an unusual variant of cutaneous T-cell lymphoma","volume":"56","author":"Vakeva","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.mcna.2021.04.010_bib27","article-title":"Follicular lymphomatoid papulosis - not a simple folliculitis","author":"Verheyden","year":"2020","journal-title":"Australas J Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.23736\/S0026-4806.19.06395-X","article-title":"Lymphomatoid papulosis","volume":"111","author":"Sica","year":"2020","journal-title":"Minerva Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jdv.16065","article-title":"Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis","volume":"34","author":"Melchers","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.010_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/ijd.IJD_16_19","article-title":"Mycosis Fungoides, Lymphomatoid Papulosis and Hodgkin's lymphoma in the same patient: apropos of a possible monoclonal origin","volume":"65","author":"Molgo","year":"2020","journal-title":"Indian J Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.010_bib31","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/bjd.13920","article-title":"Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group","volume":"173","author":"Bruijn","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ced.13256","article-title":"First-line treatment in lymphomatoid papulosis: a retrospective multicentre study","volume":"43","author":"Fernandez-de-Misa","year":"2018","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.010_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11899-020-00583-4","article-title":"Primary cutaneous CD30+ lymphoproliferative disorders: a comprehensive review","volume":"15","author":"Di Raimondo","year":"2020","journal-title":"Curr hematologic malignancy Rep"},{"issue":"12","key":"10.1016\/j.mcna.2021.04.010_bib34","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/ijd.13696","article-title":"Brentuximab vedotin in CD30(+) primary cutaneous T-cell lymphomas: a review and analysis of existing data","volume":"56","author":"Enos","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.mcna.2021.04.010_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cyto.b.21963","article-title":"International guidelines for the flow cytometric evaluation of peripheral blood for suspected Sezary syndrome or mycosis fungoides: assay development\/optimization, validation, and ongoing quality monitors","volume":"100","author":"Illingworth","year":"2021","journal-title":"Cytometry"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jid.2019.08.440","article-title":"Survival in mycosis fungoides and sezary syndrome: how can we predict outcome?","volume":"140","author":"Scarisbrick","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaad.2010.08.037","article-title":"Sezary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)","volume":"64","author":"Olsen","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.010_bib38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.6004\/jnccn.2020.0022","article-title":"NCCN guidelines insights: primary cutaneous lymphomas, version 2.2020","volume":"18","author":"Mehta-Shah","year":"2020","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.mcna.2021.04.010_bib39","first-page":"1","article-title":"The clinical spectrum of primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoproliferative disorder: an updated systematic literature review and case series","author":"Surmanowicz","year":"2020","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.mcna.2021.04.010_bib40","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.5858\/arpa.2013-0253-CR","article-title":"Lupus profundus (panniculitis): a potential mimic of subcutaneous panniculitis-like T-cell lymphoma","volume":"137","author":"Arps","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib41","doi-asserted-by":"crossref","first-page":"e14742","DOI":"10.1111\/dth.14742","article-title":"Treatment considerations in case of subcutaneous panniculitis like T\u00a0cell lymphoma with hemophagocytic syndrome","volume":"34","author":"Khemani","year":"2021","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.010_bib42","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaad.2018.05.1243","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: clinical features, therapeutic approach, and outcome in a case series of 16 patients","volume":"79","author":"Lopez-Lerma","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.010_bib43","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/bjd.17985","article-title":"Epidemiology of primary cutaneous gammadelta T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the U.S.A. from 2006 to 2015: a Surveillance, Epidemiology, and End Results-18 analysis","volume":"181","author":"Goyal","year":"2019","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.mcna.2021.04.010_bib44","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous gammadelta T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.mcna.2021.04.010_bib45","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/ijd.15393","article-title":"Complete remission with brentuximab vedotin in a case of primary cutaneous gamma-delta T-cell lymphoma relapsed after allogeneic stem cell transplantation","volume":"60","author":"Lastrucci","year":"2021","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.mcna.2021.04.010_bib46","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1080\/10428194.2020.1790555","article-title":"Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T\u00a0cell lymphomas","volume":"61","author":"Isufi","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.010_bib47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1684\/ejd.2020.3843","article-title":"Challenges in early diagnosis of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma: a case series of four patients","volume":"30","author":"Onsun","year":"2020","journal-title":"Eur J Dermatol"},{"issue":"8","key":"10.1016\/j.mcna.2021.04.010_bib48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/ijd.14391","article-title":"Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients","volume":"58","author":"Jaque","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.mcna.2021.04.010_bib49","article-title":"Staging of primary cutaneous follicle centre B-cell lymphoma: bone marrow biopsy, CD10, BCL2 and t(14;18) are not relevant prognostic factors","author":"Guinard","year":"2019","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00066-019-01541-7","article-title":"De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma","volume":"196","author":"Oertel","year":"2020","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.010_bib51","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/ajcp\/aqaa116","article-title":"How i diagnose primary cutaneous marginal zone lymphoma","volume":"154","author":"Gibson","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib52","doi-asserted-by":"crossref","first-page":"adv00383","DOI":"10.2340\/00015555-3746","article-title":"Long-term therapeutic success of intravenous rituximab in 26 patients with indolent primary cutaneous B-cell Lymphoma","volume":"101","author":"Porkert","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.mcna.2021.04.010_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/0049475521991339","article-title":"A\u00a0case of false identity: primary cutaneous diffuse large B-cell lymphoma masquerading as Madura Foot","author":"Ibrahim","year":"2021","journal-title":"Trop Doct"},{"issue":"9","key":"10.1016\/j.mcna.2021.04.010_bib54","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jdcr.2020.06.043","article-title":"Two instructive cases of primary cutaneous diffuse large B-cell lymphoma (leg type) mimicking cellulitis and sporotrichosis","volume":"6","author":"Long","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.010_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2340\/00015555-1424","article-title":"Frequent relapse and irradiation strategy in primary cutaneous diffuse large B-cell lymphoma, leg-type","volume":"93","author":"Sumida","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.mcna.2021.04.010_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2147\/DDDT.S137106","article-title":"Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data","volume":"12","author":"Liner","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"10.1016\/j.mcna.2021.04.010_bib57","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jdcr.2020.05.031","article-title":"Evaluation and management of patients with early-stage mycosis fungoides who interrupt or discontinue topical mechlorethamine gel because of dermatitis","volume":"6","author":"Gilmore","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"11","key":"10.1016\/j.mcna.2021.04.010_bib58","first-page":"e11591","article-title":"Bexarotene: a rare cause of misleading thyroid function tests","volume":"12","author":"Pattan","year":"2020","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.010_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cen.13975","article-title":"Bexarotene-induced hypothyroidism: characteristics and therapeutic strategies","volume":"91","author":"Makita","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.010_bib60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/ced.13044","article-title":"Omega-3 fatty acids as adjunctive treatment for bexarotene-induced hypertriglyceridaemia in patients with cutaneous T-cell lymphoma","volume":"42","author":"Cabello","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.010_bib61","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00280-011-1772-z","article-title":"The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer","volume":"69","author":"Wakelee","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.010_bib62","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/14740338.2020.1718103","article-title":"Risk of adverse events in lymphoma patients treated with brentuximab vedotin: a systematic review and meta-analysis","volume":"19","author":"Gao","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"10.1016\/j.mcna.2021.04.010_bib63","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/jnnp-2020-323124","article-title":"Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies","volume":"91","author":"Fargeot","year":"2020","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T19:11:25Z","timestamp":1725131485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712521000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0025712521000481"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.04.010","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}